Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020.
Wada T, Ishimoto T, Nakaya I, Kawaguchi T, Sofue T, Shimizu S, Kurita N, Sasaki S, Nishiwaki H, Koizumi M, Saito S, Nishibori N, Oe Y, Yoshida M, Miyaoka Y, Akiyama S, Itano Y, Okazaki M, Ozeki T, Ichikawa D, Oguchi H, Kohsaka S, Kosaka S, Kataoka Y, Shima H, Shirai S, Sugiyama K, Suzuki T, Son D, Tanaka T, Nango E, Niihata K, Nishijima Y, Nozu K, Hasegawa M, Miyata R, Yazawa M, Yamamoto Y, Yamamoto R, Shibagaki Y, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for Nephrotic Syndrome 2020. Wada T, et al. Among authors: hasegawa m. Clin Exp Nephrol. 2021 Dec;25(12):1277-1285. doi: 10.1007/s10157-021-02098-5. Epub 2021 Sep 26. Clin Exp Nephrol. 2021. PMID: 34564793 No abstract available.
Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy.
Yamamoto Y, Hiki Y, Nakai S, Yamamoto K, Takahashi K, Koide S, Murakami K, Tomita M, Hasegawa M, Kawashima S, Sugiyama S, Yuzawa Y. Yamamoto Y, et al. Among authors: hasegawa m. Clin Exp Nephrol. 2013 Apr;17(2):218-24. doi: 10.1007/s10157-012-0679-2. Epub 2012 Aug 29. Clin Exp Nephrol. 2013. PMID: 22926695 Free PMC article.
Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014.
Arimura Y, Muso E, Fujimoto S, Hasegawa M, Kaname S, Usui J, Ihara T, Kobayashi M, Itabashi M, Kitagawa K, Hirahashi J, Kimura K, Matsuo S. Arimura Y, et al. Among authors: hasegawa m. Clin Exp Nephrol. 2016 Jun;20(3):322-41. doi: 10.1007/s10157-015-1218-8. Clin Exp Nephrol. 2016. PMID: 27099135 Free PMC article. Review. No abstract available.
Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia.
Wada T, Hara A, Muso E, Maruyama S, Kato S, Furuichi K, Yoshimura K, Toyama T, Sakai N, Suzuki H, Tsukamoto T, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Goto S, Sakamaki Y, Yokoyama H, Mori N, Tanaka S, Yuzawa Y, Hasegawa M, Matsubara T, Wada J, Tanabe K, Masutani K, Abe Y, Tsuruya K, Fujimoto S, Iwatsubo S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Sofue T, Miyata H, Nakano T, Ohtake T, Kobayashi S; LICENSE study Group. Wada T, et al. Among authors: hasegawa m. Clin Exp Nephrol. 2021 Jan;25(1):1-8. doi: 10.1007/s10157-020-01959-9. Epub 2020 Aug 28. Clin Exp Nephrol. 2021. PMID: 32857255
Long-term changes in renal function after treatment initiation and the importance of early diagnosis in maintaining renal function among IgG4-related tubulointerstitial nephritis patients in Japan.
Arai H, Ogata S, Ozeki T, Takahashi K, Tsuboi N, Maruyama S, Inaguma D, Hasegawa M, Yuzawa Y, Hayashi H. Arai H, et al. Among authors: hasegawa m. Arthritis Res Ther. 2020 Nov 5;22(1):261. doi: 10.1186/s13075-020-02320-x. Arthritis Res Ther. 2020. PMID: 33153483 Free PMC article.
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Tsukamoto T, Uchida S, Tsuruya K, Shoji T, Hayashi H, Akai Y, Fukunaga M, Konta T, Nishio S, Goto S, Tamai H, Nagai K, Katafuchi R, Masutani K, Wada T, Nishino T, Shirasaki A, Sobajima H, Nitta K, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Akahori T, Naruse T, Hiramatsu T, Morozumi K, Mimura T, Saka Y, Ishimura E, Hasegawa H, Ichikawa D, Shigematsu T, Sato H, Narita I, Isaka Y; Japan Nephrotic Syndrome Cohort Study investigators. Yamamoto R, et al. Among authors: hasegawa h. J Nephrol. 2022 May;35(4):1135-1144. doi: 10.1007/s40620-022-01279-z. Epub 2022 Apr 2. J Nephrol. 2022. PMID: 35366214
Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Uchida S, Tsukamoto T, Tsuruya K, Akai Y, Nitta K, Fukunaga M, Hayashi H, Masutani K, Wada T, Konta T, Katafuchi R, Nishio S, Goto S, Tamai H, Shirasaki A, Shoji T, Nagai K, Nishino T, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Naruse T, Hiramatsu T, Morozumi K, Sobajima H, Saka Y, Ishimura E, Ichikawa D, Shigematsu T, Sofue T, Fujimoto S, Ito T, Sato H, Narita I, Isaka Y; JNSCS Investigators. Yamamoto R, et al. Sci Rep. 2022 Jun 13;12(1):9782. doi: 10.1038/s41598-022-13067-7. Sci Rep. 2022. PMID: 35697724 Free PMC article.
Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and Hypercholesterolemia.
Hara A, Wada T, Muso E, Maruyama S, Kato S, Furuichi K, Yoshimura K, Toyama T, Sakai N, Suzuki H, Tsukamoto T, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Goto S, Sakamaki Y, Yokoyama H, Mori N, Tanaka S, Yuzawa Y, Hasegawa M, Matsubara T, Wada J, Tanabe K, Masutani K, Abe Y, Tsuruya K, Fujimoto S, Iwatsubo S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Sofue T, Miyata H, Nakano T, Ohtake T, Kobayashi S; LICENSE study group. Hara A, et al. Among authors: hasegawa m. Blood Purif. 2023;52(4):373-381. doi: 10.1159/000527900. Epub 2022 Dec 15. Blood Purif. 2023. PMID: 36521435
4,135 results